Enter
EN
TW
EN
About UBIP
Company Overview
Milestone
2024
Nov 8
Oct 18
Oct 12
Sep 20
May 09
May 02
2023
Dec 15
Dec 05
Oct 31
Oct 25
Spe 14
Spe 4
July 24
March 10
February 7
2022
Nov 28
Nov 17
Jan 20
2021
Nov 22
Oct 5
Jun 23
Jun 11
2020
Sep 22
May 28
Apr 28
Apr 14
Feb 17
2019
Oct 24
Sep 26
Aug 13
Jun 10
Mar 13
Mar 6
Mar 4
Jan 18
Jan 16
2018
Dec 4
Oct 3
May 17
May 11
Mar 3
2017
Dec 7
2016
Dec 14
Nov 29
Oct 27
Aug 15
Jul 25
Jul 11
Feb 18
Jan 22
Jan 21
2015
Dec 30
Dec 25
Dec 22
Nov 17
Oct 28
Jul 28
Jun 23
May 28
May 8
Apr 30
Jan 27
Jan 23
2014
Jul 31
Management Team
Chairman of the Board & CEO
Vice General Manager
Technology Platform
Innovative Protein Pharmaceutical Technology Platform
Specialty Injectable Development Platform
Multicomponent Tablet Formulation Technology Platform
Long-Acting Small Molecule Drug Technology Platform
RD & Products
Pipeline
Protein Drugs
Small Molecule Pharmaceuticals
Generic Drugs
own-products
Our Patents
sFc (single chain Fc) platform
Recombinant protein
Quality
CMO/CDMO Services
Tailored Solutions
Facility & Capacity
Premier Labs
Protein Drug ◆ Advanced Technology Lab
Generic Small Molecule Drugs ◆ Advanced Technology Lab
World-Class Compliant Production Line
Pharmaceutical Regulatory Compliance Solutions
News
Press Release
Media Coverage
Contact us
Search
Search
TW
EN
Home
首頁用
About Us
Achievements
Achievements
Establish Year
2014
CMO Products
100+
CDMO Projects
50+
International Inspection
11+
Footprint(sq. ft.)
240,000
Back to the previous page
